Publications by authors named "Michael Merchlinsky"

Claim this Profile
P
Pre- and Postlicensure Animal Efficacy Studies Comparing Anthrax Antitoxins.
Raymond M Slay, Rachel Cook, Katherine Hendricks, David Boucher, Michael Merchlinsky

Clin Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History of Marburg Virus Infection to Support Medical Countermeasure Development.
Jason E Comer, Trevor Brasel, Shane Massey, David W Beasley, Chris M Cirimotich, Michael Merchlinsky

Viruses· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
Agam K Rao, Brett W Petersen, Florence Whitehill, Jafar H Razeq, Stuart N Isaacs, Michael J Merchlinsky

MMWR Morb Mortal Wkly Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History of to Support Medical Countermeasure Development.
Caroline Carbonnelle, Marie Moroso, Delphine Pannetier, Sabine Godard, Stéphane Mély, Michael J Merchlinsky

Vaccines (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of Filovirus Isolates for Vaccine Development Programs.
Daniel N Wolfe, Carol L Sabourin, Michael J Merchlinsky, William C Florence, Larry A Wolfraim

Vaccines (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rabbitpox in New Zealand White Rabbits: A Therapeutic Model for Evaluation of Poxvirus Medical Countermeasures Under the FDA Animal Rule.
Mark R Perry, Richard Warren, Michael Merchlinsky, Christopher Houchens, James V Rogers

Front Cell Infect Microbiol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and approval of tecoviromat (TPOXX), the first antiviral against smallpox.
Michael Merchlinsky, Andrew Albright, Victoria Olson, Helen Schiltz, Tyler Merkeley

Antiviral Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectromelia Virus Disease Characterization in the BALB/c Mouse: A Surrogate Model for Assessment of Smallpox Medical Countermeasures.
Jennifer Garver, Lauren Weber, Eric M Vela, Mike Anderson, Richard Warren, Michael Merchlinsky

Viruses· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
Clement A Meseda, Joseph Campbell, Arunima Kumar, Alonzo D Garcia, Michael Merchlinsky

PLoS One· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.
Alla Kachko, Galina Kochneva, Galina Sivolobova, Antonina Grazhdantseva, Tatyana Lupan, Michael Merchlinsky

Vaccine· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs.
Marina Zaitseva, Senta M Kapnick, Clement A Meseda, Elisabeth Shotwell, Lisa R King, Michael Merchlinsky

J Virol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge.
Yong He, Clement A Meseda, Russell A Vassell, Michael Merchlinsky, Jerry P Weir

Vaccine· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein.
Joan E Adamo, Clement A Meseda, Jerry P Weir, Michael J Merchlinsky

J Gen Virol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.
Clement A Meseda, Anne E Mayer, Arunima Kumar, Alonzo D Garcia, Joseph Campbell, Michael Merchlinsky

Clin Vaccine Immunol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
Yong He, Jody Manischewitz, Clement A Meseda, Michael Merchlinsky, Russell A Vassell

J Infect Dis· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.
Alonzo D García, Clement A Meseda, Anne E Mayer, Arunima Kumar, Michael Merchlinsky

Clin Vaccine Immunol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
Majid Laassri, Clement A Meseda, Ollie Williams, Michael Merchlinsky, Jerry P Weir

J Med Virol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus.
Montserrat Puig, Kathleen Mihalik, John C Tilton, Ollie Williams, Michael Merchlinsky

Hepatology· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
Agnes Jones-Trower, Alonzo Garcia, Clement A Meseda, Yong He, Carol Weiss, Michael Merchlinsky

Virology· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccinia virus nicking-joining enzyme is encoded by K4L (VACWR035).
Dawn Eckert, Ollie Williams, Clement A Meseda, Michael Merchlinsky

J Virol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A.
Weila Wang, Michael Merchlinsky, John Inman, Basil Golding

Thromb Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Clement A Meseda, Alonzo D Garcia, Arunima Kumar, Anne E Mayer, Jody Manischewitz, Michael Merchlinsky

Virology· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
Zhongqi Li, Steven A Rubin, Rolf E Taffs, Michael Merchlinsky, Zhiping Ye

Vaccine· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel vaccinia-neutralization assay based on reporter-gene expression.
Jody Manischewitz, Lisa R King, Nicole A Bleckwenn, Joseph Shiloach, Rolf Taffs, Michael Merchlinsky

J Infect Dis· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
Clement A Meseda, Karen L Elkins, Michael J Merchlinsky, Jerry P Weir

J Infect Dis· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis